Analysts are more negative on Core Laboratories after recent...

Analysts are more negative on Core Laboratories after recent results, leading to a minor EPS downgrade for next year. Despite this, the unchanged consensus price target suggests lower forecast earnings won't affect the stock price. However, the company's revenue growth is expected to lag the industry average.